1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Regenerative Medical Technology Group Inc.

Regenerative Medical Technology Group Inc.

RMTG
Regenerative Medical Technology Group Inc.US flagOther OTC
0.11
USD
+0.02
- -
1.38MMarket Cap

Income Statement (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
2
2
4
5
+ Sales & Services Revenue
- -
- -
- -
- -
- -
2
2
4
5
- Cost of Revenue
- -
- -
- -
- -
- -
1
1
1
2
+ Cost of Goods & Services
- -
- -
- -
- -
- -
1
1
1
2
Gross Profit
- -
- -
- -
- -
- -
1
2
3
3
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
1
- -
2
- -
10
2
2
3
4
+ Selling, General & Admin
1
- -
2
- -
10
2
2
2
3
+ Research & Development
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-1
- -
-2
- -
-10
-1
-1
- -
-1
- Non-Operating (Income) Loss
- -
2
1
5
3
4
9
6
7
+ Interest Expense, Net
- -
1
1
4
3
4
6
6
7
+ Interest Expense
- -
1
1
4
3
4
6
6
7
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
-1
1
- -
1
- -
- -
3
- -
-1
Pretax Income
- -
-2
-3
-6
-13
-6
-10
-6
-8
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
- -
-2
-3
-6
-13
-6
-10
-6
-8
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
- -
-2
-3
-6
-13
-6
-10
-6
-8
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-2
-3
-6
-13
-6
-10
-6
-8
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
- -
-2
-3
-6
-13
-6
-10
-6
-8
EBIT
-1
- -
-2
- -
-10
-1
-1
- -
-1
EBITDA
-1
- -
-2
- -
-10
-1
- -
- -
-1
EBITDA Margin (%)
-1,712.12
-508.81
-5,282.89
-812.64
-2,255.99
-67.45
-16.81
7.35
-11.49
EBITA
-1
- -
-2
- -
-10
-1
-1
- -
-1
Gross Margin (%)
83.55
-36.35
-84.45
20.2
34.29
57.31
69.53
68.73
55.11
Operating Margin (%)
-1,712.12
-509.2
-5,285.55
-814.1
-2,265.32
-77.43
-29.68
1.98
-17
Profit Margin (%)
-1,289.31
-4,105.61
-8,335.2
-10,703.47
-2,942.42
-359.87
-407.21
-135.43
-153.18
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
3
4
5
9
11
12
12
13
13
Basic EPS, GAAP
-0.11
-0.5
-0.47
-0.63
-1.12
-0.45
-0.79
-0.44
-0.62
Basic EPS from Cont Ops
-0.11
-0.5
-0.47
-0.63
-1.12
-0.46
-0.79
-0.44
-0.62
Diluted Weighted Avg Shares
3
4
5
9
11
12
12
13
13
Diluted EPS, GAAP
-0.11
-0.5
-0.47
-0.63
-1.12
-0.45
-0.79
-0.44
-0.62
Diluted EPS from Cont Ops
-0.11
-0.5
-0.47
-0.63
-1.12
-0.46
-0.79
-0.44
-0.62

Balance Sheet (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
- -
- -
- -
- -
3
2
1
1
1
+ Cash, Cash Equivalents & STI
- -
- -
- -
- -
3
2
1
1
1
+ Cash & Cash Equivalents
- -
- -
- -
- -
3
2
1
1
1
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
- -
6
6
2
3
3
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
- -
- -
1
1
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- -
1
1
2
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
- -
1
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
6
6
2
2
2
+ Total Intangible Assets
- -
- -
- -
- -
6
6
2
2
2
+ Goodwill
- -
- -
- -
- -
6
6
2
2
2
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
- -
- -
- -
- -
9
8
3
4
4
+ Payables & Accruals
1
1
1
1
2
5
7
11
17
+ Accounts Payable
- -
- -
- -
- -
- -
- -
- -
1
- -
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
1
- -
2
5
7
11
17
+ ST Debt
- -
1
1
- -
2
7
15
18
17
+ ST Borrowings
- -
1
1
- -
2
7
15
18
17
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
1
3
5
- -
- -
- -
- -
- -
3
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
1
3
5
- -
- -
- -
- -
- -
2
Total Current Liabilities
3
5
7
1
4
12
22
29
37
+ LT Debt
- -
- -
- -
6
12
8
2
2
2
+ LT Borrowings
- -
- -
- -
6
12
8
2
2
2
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
- -
- -
- -
6
12
8
2
2
2
Total Liabilities
3
5
7
7
16
20
25
31
39
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
21
21
21
27
40
40
40
40
41
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
21
21
21
27
40
40
40
40
41
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-23
-25
-28
-34
-47
-52
-62
-68
-75
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-3
-5
-7
-6
-7
-12
-22
-27
-35
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-3
-5
-7
-6
-7
-12
-22
-27
-35
Total Liabilities & Equity
- -
- -
- -
- -
9
8
3
4
4
Shares Outstanding
5
5
8
11
12
12
12
13
13
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
- -
1
Net Debt
- -
1
2
6
11
13
17
19
18
Net Debt to Equity
-14.45
-17.23
-21.53
-89.5
-157.54
-112.36
-78.54
-68.02
-51.76
Tangible Common Equity Ratio
-32,612.43
-13,108.53
-27,890.12
-2,917.12
-426.93
-944.57
-2,517.88
-1,472.76
-1,328.15
Current Ratio
- -
0.01
- -
0.05
0.72
0.14
0.03
0.04
0.03
Cash Conversion Cycle
- -
-2,009.85
-2,655.15
-3,317.49
-346.22
-111.27
-160.14
-135.37
-52.38

Cash Flow Statement (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
- -
-2
-3
-6
-13
-6
-10
-6
-8
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
1
2
2
4
1
2
6
2
1
+ Stock-Based Compensation
- -
- -
1
- -
- -
- -
- -
- -
- -
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
4
- -
- -
+ Other Non-Cash Adj
1
2
1
4
1
2
2
2
1
+ Chg in Non-Cash Work Cap
- -
- -
- -
1
2
2
3
4
6
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc (Dec) in Accts Payable
- -
- -
- -
1
2
3
3
4
6
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
- -
- -
- -
- -
-10
-1
- -
1
-1
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
-1
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
-1
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Increase in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
1
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
1
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
1
- -
- -
- -
-1
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
1
12
- -
- -
- -
1
+ Cash From Debt
- -
- -
- -
1
12
- -
- -
- -
1
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
- -
- -
1
12
- -
- -
- -
1
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
- -
- -
- -
3
-1
-1
1
- -
EBITDA
-1
- -
-2
- -
-10
-1
- -
- -
-1
EBITDA Margin (%)
-1,712.12
-508.81
-5,282.89
-812.64
-2,255.99
-67.45
-16.81
7.35
-11.49
Free Cash Flow
- -
- -
- -
- -
-10
-1
-1
1
-1
Net Cash Paid for Acquisitions
- -
- -
- -
- -
-1
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
- -
- -
- -
3
-1
-1
1
- -
Free Cash Flow per Basic Share
- -
-0.06
-0.07
-0.03
-0.86
-0.11
-0.06
0.05
-0.1
Price/Free Cash Flow
-56.69
-0.83
-0.29
-0.93
-0.31
-0.25
-2.7
0.34
-5.96
Cash Flow to Net Income
0.02
0.12
0.14
0.05
0.77
0.2
0.04
-0.15
0.09
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -
- -
-1